These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 1453606)

  • 1. Ketodiet, physiological calcium intake and native vitamin D improve renal osteodystrophy.
    Lafage MH; Combe C; Fournier A; Aparicio M
    Kidney Int; 1992 Nov; 42(5):1217-25. PubMed ID: 1453606
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Renal osteodystrophy--pathogenesis and treatment.
    Cushner HM; Adams ND
    Am J Med Sci; 1985 Dec; 290(6):234-45. PubMed ID: 3909812
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Review: Renal osteodystrophy--pathogenesis and treatment.
    Cushner HM; Adams ND
    Am J Med Sci; 1986 Apr; 291(4):264-75. PubMed ID: 3518448
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Changes in mineral metabolism in stage 3, 4, and 5 chronic kidney disease (not on dialysis)].
    Lorenzo Sellares V; Torregrosa V
    Nefrologia; 2008; 28 Suppl 3():67-78. PubMed ID: 19018742
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The pathogenesis of renal osteodystrophy: role of vitamin D, aluminium, parathyroid hormone, calcium and phosphorus.
    Dunstan CR; Hills E; Norman AW; Bishop JE; Mayer E; Wong SY; Johnson JR; George CR; Collett P; Kalowski S
    Q J Med; 1985 May; 55(217):127-44. PubMed ID: 4001311
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Renal osteodystrophy: alpha-Heremans Schmid glycoprotein/fetuin-A, matrix GLA protein serum levels, and bone histomorphometry.
    Coen G; Ballanti P; Balducci A; Grandi F; Manni M; Mantella D; Pierantozzi A; Ruggeri M; Sardella D; Sorbo G; Bonucci E
    Am J Kidney Dis; 2006 Jul; 48(1):106-13. PubMed ID: 16797392
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The clinical spectrum of renal osteodystrophy in 57 chronic hemodialysis patients: a correlation between biochemical parameters and bone pathology findings.
    Chazan JA; Libbey NP; London MR; Pono L; Abuelo JG
    Clin Nephrol; 1991 Feb; 35(2):78-85. PubMed ID: 2019018
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bone mass and dynamic parathyroid function according to bone histology in nondialyzed uremic patients after long-term protein and phosphorus restriction.
    Lafage-Proust MH; Combe C; Barthe N; Aparicio M
    J Clin Endocrinol Metab; 1999 Feb; 84(2):512-9. PubMed ID: 10022409
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Calcium and phosphorus metabolism in chronic uremia.
    Fiaschi E; Mioni G; Maschio G; D'Angelo A; Ossi E
    Nephron; 1975; 14(2):163-80. PubMed ID: 1093055
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term control of hyperparathyroidism in advanced renal failure by low-phosphorus low-protein diet supplemented with calcium (without changes in plasma calcitriol).
    Combe C; Morel D; de Précigout V; Blanchetier V; Bouchet JL; Potaux L; Fournier A; Aparicio M
    Nephron; 1995; 70(3):287-95. PubMed ID: 7477615
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Renal osteodystrophy.
    Coburn JW; Henry DA
    Adv Intern Med; 1984; 30():387-424. PubMed ID: 6397042
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Renal osteodystrophy (3); its treatment in dialysis patients].
    Ghitu S; Oprisiu R; Benamar L; Said S; Tataru Albu A; Arsenescu I; el Esper N; Morinière P; Fournier A
    Nephrologie; 2000; 21(8):413-24. PubMed ID: 11213385
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [A pathological analysis of 51 cases of renal osteodystrophy].
    Yu YF; Hu YX; Zhu P
    Zhonghua Nei Ke Za Zhi; 1993 Jul; 32(7):448-50. PubMed ID: 8275821
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pathophysiology and recent advances in the management of renal osteodystrophy.
    Elder G
    J Bone Miner Res; 2002 Dec; 17(12):2094-105. PubMed ID: 12469904
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Extent of alkaline phosphatase cytochemistry vs. extent of tetracycline fluorescence in the evaluation of histodynamic variables of bone formation.
    Ballanti P; Coen G; Taggi F; Mazzaferro S; Perruzza I; Bonucci E
    Bone; 1995 May; 16(5):493-8. PubMed ID: 7654463
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationship between serum vitamin D metabolites and dietary intake of phosphate in patients with early renal failure.
    Tessitore N; Venturi A; Adami S; Roncari C; Rugiu C; Corgnati A; Bonucci E; Maschio G
    Miner Electrolyte Metab; 1987; 13(1):38-44. PubMed ID: 3587183
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Renal bone disease: a new conceptual framework for the interpretation of bone histomorphometry.
    Parfitt AM
    Curr Opin Nephrol Hypertens; 2003 Jul; 12(4):387-403. PubMed ID: 12815335
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Renal osteodystrophy: pathophysiology and treatment.
    Fournier A; Sebert JL; Moriniere P; Gregoire I; de Fremont JF; Tahiri Y; Dkhissi H
    Horm Res; 1984; 20(1):44-58. PubMed ID: 6378747
    [No Abstract]   [Full Text] [Related]  

  • 19. [Pathological analysis of renal osteodystrophy in 194 cases].
    Yu YF
    Zhonghua Bing Li Xue Za Zhi; 1991 Dec; 20(4):280-3. PubMed ID: 1813163
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Elevated bone aluminum and suppressed parathyroid hormone levels in hypercalcemic dialysis patients.
    Piraino B; Chen T; Puschett JB
    Am J Nephrol; 1989; 9(3):190-7. PubMed ID: 2757078
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.